Imexpharm aims for quality and affordability

A panorama picture of Imexpharm’s factory in Binh Duong province that met EU-GMP standards - Viet Nam News/ANN

Hanoi: “Vietnam is one of the fast-growing pharmaceutical markets in the world,” says Tran Thi Dao, general director of Imexpharm, adding that “after the Covid-19 pandemic, the country’s pharmaceutical industry still maintains growth momentum even though some other industries show signs of slowing down”.

According to a recent report by the Drug Administration of Vietnam, the total value of Vietnam’s pharmaceutical market was estimated to increase from about US$2.7bil in 2015 to US$7bil in 2022.